Agomab Therapeutics NV (AGMB) Short term Debt (2025 - 2026)
Agomab Therapeutics (AGMB) posted Short term Debt of $7.8 million for Q2 2026, up 3.08% on a QoQ basis from $7.6 million in Q4 2025.
Powered by 
Analysis
Agomab Therapeutics NV (AGMB) Short term Debt (2025 - 2026) Analysis & Trends
Agomab Therapeutics has reported Short term Debt for 2 years, with the latest figure at $7.8 million in Q2 2026.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $7.8 million in Q2 2026; TTM through Jun 2026 was $7.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.6 million, changed N/A from the prior year.
- Short term Debt was $7.8 million for Q2 2026 at Agomab Therapeutics, up from $7.6 million in the prior quarter.
- The five-year high for Short term Debt was $7.8 million in Q2 2026, with the low at $7.6 million in Q4 2025.
Peer Set
Peer Comparison
API Access
Agomab Therapeutics NV Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();